Marshall Wace’s Niagen Bioscience NAGE Stock Holding History

Marshall Wace’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$57.6K	Buy	+18,059	New	+$73.3K	﹤0.01%	2981
2025 Q3	–	Sell	-162,133	Closed	-$2.34M	–	3526
2025 Q2	$2.34M	Sell	162,133 -136,844	-46%	-$1.35M	﹤0.01%	1484
2025 Q1	$2.06M	Buy	+298,977	New	+$1.88M	﹤0.01%	1450
2024 Q3	–	Sell	-20,577	Closed	-$56.2K	–	3047
2024 Q2	$56.2K	Buy	+20,577	New	+$68.9K	﹤0.01%	2439
2023 Q2	–	Sell	-34,600	Closed	-$52.9K	–	3059
2023 Q1	$52.9K	Sell	34,600 -47,492	-58%	-$84.5K	﹤0.01%	2537
2022 Q4	$138K	Hold	82,092	–	–	﹤0.01%	2754
2022 Q3	$101K	Buy	82,092 +32,641	+66%	+$52.5K	﹤0.01%	3180
2022 Q2	$83K	Sell	49,451 -28,620	-37%	-$56K	﹤0.01%	3298
2022 Q1	$193K	Buy	+78,071	New	+$213K	﹤0.01%	3114
2021 Q4	–	Sell	-88,868	Closed	-$557K	–	4357
2021 Q3	$557K	Buy	88,868 +10,140	+13%	+$83.6K	﹤0.01%	2332
2021 Q2	$776K	Sell	78,728 -184,114	-70%	-$1.61M	﹤0.01%	1933
2021 Q1	$2.46M	Buy	+262,842	New	+$2.08M	0.01%	1214

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace's NAGE Position: Q2 2026 in Review

Marshall Wace opened a new position in Niagen Bioscience (NAGE) in Q2 2026: 18,059 shares worth $57.6K. The stake represents ﹤0.01% of the portfolio and ranks #2981 among its holdings. This is a return to the name: Marshall Wace previously reported a position in NAGE as recently as Q2 2025.

Marshall Wace first reported a position in NAGE in Q1 2021 and has held it in 12 quarters since. The position peaked at $2.46M in Q1 2021. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

Marshall Wace held 18,059 shares of Niagen Bioscience worth $57.6K as of Q2 2026.
Niagen Bioscience was a new Marshall Wace position in Q2 2026.
Niagen Bioscience made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2981 holding.
Marshall Wace first reported a position in Niagen Bioscience in Q1 2021 and has held it in 12 quarters since.
Marshall Wace's Niagen Bioscience position peaked at $2.46M in Q1 2021.
140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.